Published in Pain on March 03, 2012
Parkinson's disease patients with pain suffer from more severe non-motor symptoms. Neurol Sci (2014) 1.40
Psychological processing in chronic pain: a neural systems approach. Neurosci Biobehav Rev (2013) 1.19
Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats. J Pain (2013) 1.18
Pain, decisions, and actions: a motivational perspective. Front Neurosci (2013) 1.09
Pain and suicidality: insights from reward and addiction neuroscience. Prog Neurobiol (2013) 1.08
Evaluation of reward from pain relief. Ann N Y Acad Sci (2013) 1.01
Role of nucleus accumbens in neuropathic pain: linked multi-scale evidence in the rat transitioning to neuropathic pain. Pain (2014) 0.98
Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous κ-opioids. Neuropsychopharmacology (2013) 0.98
Microglia disrupt mesolimbic reward circuitry in chronic pain. J Neurosci (2015) 0.93
Does the kappa opioid receptor system contribute to pain aversion? Front Pharmacol (2014) 0.92
Effects of the triple monoamine uptake inhibitor amitifadine on pain-related depression of behavior and mesolimbic dopamine release in rats. Pain (2015) 0.85
Dopamine precursor depletion influences pain affect rather than pain sensation. PLoS One (2014) 0.84
Modulation of pain, nociception, and analgesia by the brain reward center. Neuroscience (2016) 0.83
Dopamine and pain sensitivity: neither sulpiride nor acute phenylalanine and tyrosine depletion have effects on thermal pain sensations in healthy volunteers. PLoS One (2013) 0.81
Mesolimbic dopamine signaling in acute and chronic pain: implications for motivation, analgesia, and addiction. Pain (2016) 0.80
Inflammatory Pain Promotes Increased Opioid Self-Administration: Role of Dysregulated Ventral Tegmental Area μ Opioid Receptors. J Neurosci (2015) 0.79
Days with pain and substance use disorders: is there an association? Clin J Pain (2013) 0.79
Parkinson's disease patients' subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life. Neuropsychiatr Dis Treat (2012) 0.79
Homers at the Interface between Reward and Pain. Front Psychiatry (2013) 0.79
Electroencephalographic Patterns in Chronic Pain: A Systematic Review of the Literature. PLoS One (2016) 0.79
Frontostriatal Gating of Tinnitus and Chronic Pain. Trends Cogn Sci (2015) 0.79
Mu Opioid Receptor Modulation of Dopamine Neurons in the Periaqueductal Gray/Dorsal Raphe: A Role in Regulation of Pain. Neuropsychopharmacology (2016) 0.79
Positive emotions and brain reward circuits in chronic pain. J Comp Neurol (2016) 0.78
Dopamine is produced in the rat spinal cord and regulates micturition reflex after spinal cord injury. Exp Neurol (2015) 0.77
Exploring Genetic Susceptibility to Fibromyalgia. Chonnam Med J (2015) 0.76
GABA-A receptor activity in the noradrenergic locus coeruleus drives trigeminal neuropathic pain in the rat; contribution of NAα1 receptors in the medial prefrontal cortex. Neuroscience (2016) 0.76
Classification and Characteristics of Pain Associated with Parkinson's Disease. Parkinsons Dis (2016) 0.75
Clinical Pain and Neuropsychological Functioning in Parkinson's Disease: Are They Related? Parkinsons Dis (2016) 0.75
Disrupted central inhibition after transcranial magnetic stimulation of motor cortex in schizophrenia with long-term antipsychotic treatment. ISRN Psychiatry (2013) 0.75
Dysautonomia Differentially Influences the Effect of Affective Pain Perception on Quality of Life in Parkinson's Disease Patients. Parkinsons Dis (2016) 0.75
Effect of Motor Impairment on Analgesic Efficacy of Dopamine D2/3 Receptors in a Rat Model of Neuropathy. J Exp Neurosci (2016) 0.75
Heightened eating drive and visual food stimuli attenuate central nociceptive processing. J Neurophysiol (2014) 0.75
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 58.92
Predictive reward signal of dopamine neurons. J Neurophysiol (1998) 15.02
Depression and pain comorbidity: a literature review. Arch Intern Med (2003) 11.34
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci (1973) 7.85
Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain (2005) 7.80
The mesolimbic dopamine reward circuit in depression. Biol Psychiatry (2006) 7.62
Multiple dopamine functions at different time courses. Annu Rev Neurosci (2007) 6.18
How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl) (2001) 6.00
Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet (2004) 5.87
Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci (2006) 5.70
Neurocircuitry of mood disorders. Neuropsychopharmacology (2010) 5.57
Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol (2006) 5.40
Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci (2003) 4.84
COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science (2003) 4.72
The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry (2007) 4.51
Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA (2003) 4.25
Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem (1958) 4.16
Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse (1993) 4.13
Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry (1995) 4.10
Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience (1991) 4.05
Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience (2000) 3.95
Classical fear conditioning in the anxiety disorders: a meta-analysis. Behav Res Ther (2005) 3.83
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry (2004) 3.80
The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology (2004) 3.51
State-dependent opioid control of pain. Nat Rev Neurosci (2004) 3.51
Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science (2001) 3.48
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry (2008) 3.47
A common neurobiology for pain and pleasure. Nat Rev Neurosci (2008) 3.45
Pain-related fear is more disabling than pain itself: evidence on the role of pain-related fear in chronic back pain disability. Pain (1999) 3.40
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A (2000) 3.34
Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry (2006) 3.24
Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain (1997) 3.12
Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain. Neuron (2010) 3.11
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A (1992) 3.02
Individual differences in reward responding explain placebo-induced expectations and effects. Neuron (2007) 2.96
Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry (1999) 2.90
The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry (1998) 2.88
Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci (1998) 2.81
Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci (2009) 2.78
Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem (1989) 2.75
Dopamine and the regulation of cognition and attention. Prog Neurobiol (2002) 2.72
Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci U S A (1995) 2.66
Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry (2002) 2.56
Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol Psychiatry (2009) 2.54
Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches. Prog Neuropsychopharmacol Biol Psychiatry (2003) 2.52
Chronic pain patients are impaired on an emotional decision-making task. Pain (2004) 2.50
Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci (2007) 2.38
Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry (1991) 2.30
Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther (1988) 2.29
Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology (2000) 2.28
A cross-national study of the course of persistent pain in primary care. Pain (2001) 2.26
Fear and anxiety: divergent effects on human pain thresholds. Pain (2000) 2.24
Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain (2003) 2.24
Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev (1991) 2.22
Pain in Parkinson's disease: Prevalence and characteristics. Pain (2008) 2.18
Understanding how opioids contribute to reward and analgesia. Reg Anesth Pain Med (2007) 2.14
Pain catastrophizing: a critical review. Expert Rev Neurother (2009) 2.10
Direct and indirect pathways from the amygdala to the frontal lobe in rhesus monkeys. J Comp Neurol (1981) 2.00
Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol (2008) 1.96
Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res (1995) 1.90
Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med (2005) 1.89
Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res (2003) 1.88
Dopamine receptor subtypes: beyond the D1/D2 classification. Trends Pharmacol Sci (1990) 1.85
The association of persistent pain with out-patient addiction treatment outcomes and service utilization. Addiction (2008) 1.82
Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity. J Neurosci (2006) 1.79
Genetic gating of human fear learning and extinction: possible implications for gene-environment interaction in anxiety disorder. Psychol Sci (2009) 1.76
Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend (2004) 1.71
Dopamine and migraine. Neurology (1997) 1.70
Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse (1994) 1.68
Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J Clin Psychiatry (2002) 1.66
The role of the basal ganglia in nociception and pain. Pain (1995) 1.65
Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends Neurosci (1991) 1.65
Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet (2003) 1.64
Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci (2007) 1.63
Persistent pain is associated with substance use after detoxification: a prospective cohort analysis. Addiction (2007) 1.62
Prospective study on the relationship between depressive symptoms and chronic musculoskeletal pain. Pain (1994) 1.61
Low dopamine D(2) receptor binding potential in social phobia. Am J Psychiatry (2000) 1.58
Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors. Pain (2006) 1.57
Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int (2002) 1.55
The primate thalamus is a key target for brain dopamine. J Neurosci (2005) 1.52
Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. Am J Addict (2008) 1.52
Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia (2002) 1.51
Parkinson's disease and anxiety: comorbidity with depression. Biol Psychiatry (1993) 1.51
Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette. Neuropsychopharmacology (2008) 1.49
Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management. Pain (2005) 1.46
Neural substrates of reward magnitude, probability, and risk during a wheel of fortune decision-making task. Neuroimage (2008) 1.45
Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. J Pharmacol Exp Ther (1997) 1.41
Pain insensitivity in schizophrenia: a neglected phenomenon and some implications. Schizophr Bull (1994) 1.40
Effects of attention on the intensity and unpleasantness of thermal pain. Pain (1989) 1.40
Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology (1994) 1.38
Role of the dopaminergic system in chronic pain -- a fluorodopa-PET study. Pain (2001) 1.37
Disruption of attention and working memory traces in individuals with chronic pain. Anesth Analg (2007) 1.35
Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends Neurosci (1997) 1.33
Gene-gene effects on central processing of aversive stimuli. Mol Psychiatry (2007) 1.32
Reward-aversion circuitry in analgesia and pain: implications for psychiatric disorders. Eur J Pain (2006) 1.31
Painful Parkinson's disease. Lancet (1986) 1.31
Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain (2003) 1.29
Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype. Brain (2008) 1.28
Corticolimbic dysregulation and chronic methamphetamine abuse. Addiction (2007) 1.28
D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene. Mol Psychiatry (1998) 1.26
AGA technical review on irritable bowel syndrome. Gastroenterology (2002) 6.76
Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci (2004) 4.14
Studying sex and gender differences in pain and analgesia: a consensus report. Pain (2007) 3.58
Neural systems and cue-induced cocaine craving. Neuropsychopharmacology (2002) 3.50
Brain metabolic changes during cigarette craving. Arch Gen Psychiatry (2002) 3.16
Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients. Gastroenterology (2006) 2.95
Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci (2009) 2.78
Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend (2005) 2.67
Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry (2006) 2.53
Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci (2004) 2.42
Sex-related differences in IBS patients: central processing of visceral stimuli. Gastroenterology (2003) 2.32
Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology (2013) 2.26
Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol (2009) 2.24
Neural substrates of resisting craving during cigarette cue exposure. Biol Psychiatry (2007) 2.23
Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol Psychiatry (2004) 2.20
Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology (2006) 2.15
Frontoparietal cortical activity of methamphetamine-dependent and comparison subjects performing a delay discounting task. Hum Brain Mapp (2007) 2.11
Decision-making in a risk-taking task: a PET study. Neuropsychopharmacology (2002) 2.07
Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry (2006) 2.00
Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers. J Neurosci (2006) 1.99
Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia. Am J Physiol Gastrointest Liver Physiol (2005) 1.99
Smoking-induced ventral striatum dopamine release. Am J Psychiatry (2004) 1.92
Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology (2010) 1.90
Leptin replacement alters brain response to food cues in genetically leptin-deficient adults. Proc Natl Acad Sci U S A (2007) 1.89
Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol (2011) 1.89
Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome? Gastrointest Endosc (2005) 1.88
Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage (2003) 1.87
Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning. J Neurosci (2011) 1.82
Psychometric properties of the Early Trauma Inventory-Self Report. J Nerv Ment Dis (2007) 1.81
Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome. J Neurosci (2008) 1.77
Regional gray matter density changes in brains of patients with irritable bowel syndrome. Gastroenterology (2010) 1.75
Decision making in adolescents with behavior disorders and adults with substance abuse. Am J Psychiatry (2003) 1.74
Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence. Addict Behav (2005) 1.69
The neural correlates of placebo effects: a disruption account. Neuroimage (2004) 1.68
The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index. Psychosom Med (2007) 1.65
Gut/brain axis and the microbiota. J Clin Invest (2015) 1.64
An update on the use and investigation of probiotics in health and disease. Gut (2013) 1.62
The MAPP research network: design, patient characterization and operations. BMC Urol (2014) 1.56
Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study. Psychiatry Res (2004) 1.55
Abuse of amphetamines and structural abnormalities in the brain. Ann N Y Acad Sci (2008) 1.54
Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol (2007) 1.54
Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome. Am J Gastroenterol (2005) 1.52
Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. Arch Intern Med (2004) 1.51
Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress. Am J Gastroenterol (2003) 1.50
Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette. Neuropsychopharmacology (2008) 1.49
One-year test-retest reliability of intrinsic connectivity network fMRI in older adults. Neuroimage (2012) 1.47
The MAPP research network: a novel study of urologic chronic pelvic pain syndromes. BMC Urol (2014) 1.47
Diminished neurokinin-1 receptor availability in patients with two forms of chronic visceral pain. Pain (2013) 1.45
Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans. J Neurosci (2012) 1.44
Effect of leptin replacement on brain structure in genetically leptin-deficient adults. J Clin Endocrinol Metab (2005) 1.44
Developing irritable bowel syndrome guidelines through meta-analyses: does the emperor really have new clothes? Gastroenterology (2009) 1.43
Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence. Biol Psychiatry (2005) 1.43
Impact of Mindfulness-Based Stress Reduction training on intrinsic brain connectivity. Neuroimage (2011) 1.42
Dopamine D2/D3 receptors play a specific role in the reversal of a learned visual discrimination in monkeys. Neuropsychopharmacology (2007) 1.42
Prevalence of irritable bowel syndrome among university students: the roles of worry, neuroticism, anxiety sensitivity and visceral anxiety. J Psychosom Res (2003) 1.40
Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette. Int J Neuropsychopharmacol (2008) 1.39
PET studies of the influences of nicotine on neural systems in cigarette smokers. Am J Psychiatry (2003) 1.38
Inhibitory control deficits in childhood and risk for substance use disorders: a review. Am J Drug Alcohol Abuse (2008) 1.36
Neural substrates of decision making in adults with attention deficit hyperactivity disorder. Am J Psychiatry (2003) 1.36
Predictors of patient-assessed illness severity in irritable bowel syndrome. Am J Gastroenterol (2008) 1.35
Association between early adverse life events and irritable bowel syndrome. Clin Gastroenterol Hepatol (2011) 1.35
Gender effects on mood and cigarette craving during early abstinence and resumption of smoking. Nicotine Tob Res (2008) 1.34
Different forms of self-control share a neurocognitive substrate. J Neurosci (2011) 1.33
Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. Gastroenterology (2009) 1.33
Behavioral predictors of substance-use initiation in adolescents with and without attention-deficit/hyperactivity disorder. Pediatrics (2006) 1.29
The effect of life stress on symptoms of heartburn. Psychosom Med (2004) 1.28
Corticolimbic dysregulation and chronic methamphetamine abuse. Addiction (2007) 1.28
Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction (2010) 1.27
2-[18F]F-A-85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans. FASEB J (2003) 1.26
Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence. J Stud Alcohol Drugs (2010) 1.24
Early adverse life events and resting state neural networks in patients with chronic abdominal pain: evidence for sex differences. Psychosom Med (2014) 1.24
Risky decision making and the anterior cingulate cortex in abstinent drug abusers and nonusers. Brain Res Cogn Brain Res (2005) 1.23
Role of astrocytes and altered regulation of spinal glutamatergic neurotransmission in stress-induced visceral hyperalgesia in rats. Am J Physiol Gastrointest Liver Physiol (2011) 1.22
Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome. Gastroenterology (2011) 1.22
Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study. Gastroenterology (2007) 1.22
Graphical analysis of 2-[18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain. Synapse (2003) 1.21
Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine. Drug Alcohol Depend (2012) 1.20
The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease. Gastroenterology (2007) 1.19
Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. Drug Alcohol Depend (2006) 1.19
A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther (2011) 1.18
Genetic approaches to functional gastrointestinal disorders. Gastroenterology (2010) 1.18
Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals. Neuropsychopharmacology (2011) 1.18
Prefrontal hypoactivation during cognitive control in early abstinent methamphetamine-dependent subjects. Psychiatry Res (2011) 1.17
Functional abdominal pain syndrome. Gastroenterology (2006) 1.16
Sex differences in striatal dopamine D2/D3 receptor availability in smokers and non-smokers. Int J Neuropsychopharmacol (2012) 1.14
Effect of sex on perception of rectosigmoid stimuli in irritable bowel syndrome. Am J Physiol Regul Integr Comp Physiol (2006) 1.14
Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers. Arch Gen Psychiatry (2011) 1.14
Corticotropin-releasing factor receptor 1 mediates acute and delayed stress-induced visceral hyperalgesia in maternally separated Long-Evans rats. Am J Physiol Gastrointest Liver Physiol (2005) 1.12
Two N-methyl-D-aspartate receptors in rat dorsal root ganglia with different subunit composition and localization. J Comp Neurol (2002) 1.12
Patients with chronic visceral pain show sex-related alterations in intrinsic oscillations of the resting brain. J Neurosci (2013) 1.11
A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS. Am J Gastroenterol (2005) 1.11
A novel water-soluble selective CRF1 receptor antagonist, NBI 35965, blunts stress-induced visceral hyperalgesia and colonic motor function in rats. Brain Res (2003) 1.11
Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. Drug Alcohol Depend (2009) 1.11
Sex differences in regional brain response to aversive pelvic visceral stimuli. Am J Physiol Regul Integr Comp Physiol (2006) 1.10
Smoking reduces conflict-related anterior cingulate activity in abstinent cigarette smokers performing a Stroop task. Neuropsychopharmacology (2009) 1.09
Dysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure. J Neurosci (2012) 1.09
An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans. Neuropsychopharmacology (2012) 1.09
Gastrointestinal and psychological mediators of health-related quality of life in IBS and IBD: a structural equation modeling analysis. Am J Gastroenterol (2011) 1.09